HomeCompareACC vs JNJ

ACC vs JNJ: Dividend Comparison 2026

ACC yields 40.94% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACC wins by $1.32M in total portfolio value
10 years
ACC
ACC
● Live price
40.94%
Share price
$65.42
Annual div
$26.78
5Y div CAGR
11.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.35M
Annual income
$527,925.04
Full ACC calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — ACC vs JNJ

📍 ACC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACC
Annual income on $10K today (after 15% tax)
$3,479.85/yr
After 10yr DRIP, annual income (after tax)
$448,736.28/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, ACC beats the other by $444,698.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACC + JNJ for your $10,000?

ACC: 50%JNJ: 50%
100% JNJ50/50100% ACC
Portfolio after 10yr
$691.2K
Annual income
$266,337.46/yr
Blended yield
38.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACC
Analyst Ratings
11
Buy
10
Hold
1
Sell
Consensus: Buy
Price Target
$65.49
+0.1% upside vs current
Range: $65.47 — $65.50
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACC buys
0
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
Diana Harshbarger🏢 House$ACC▼ Sell$1,001 - $15,0002022-08-10
Diana Harshbarger🏢 House$ACC▼ Sell$1,001 - $15,0002022-08-10
Diana Harshbarger🏢 House$ACC▼ Sell$1,001 - $15,0002022-08-10
Diana Harshbarger🏢 House$ACC▼ Sell$1,001 - $15,0002022-04-05
Diana Harshbarger🏢 House$ACC▼ Sell$1,001 - $15,0002022-04-05
Josh Gottheimer🏢 House$ACC▼ Sell$1,001 - $15,0002017-08-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACCJNJ
Forward yield40.94%2.14%
Annual dividend / share$26.78$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR11.9%28%
Portfolio after 10y$1.35M$30.5K
Annual income after 10y$527,925.04$4,749.88
Total dividends collected$1.21M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$65.49$228.73

Year-by-year: ACC vs JNJ ($10,000, DRIP)

YearACC PortfolioACC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,281$4,581.13$10,594$274.49+$4.7KACC
2$23,672$7,321.06$11,294$360.69+$12.4KACC
3$37,189$11,860.35$12,133$476.91+$25.1KACC
4$59,279$19,486.26$13,156$635.42+$46.1KACC
5$95,911$32,483.03$14,432$854.61+$81.5KACC
6$157,588$54,963.40$16,056$1,162.76+$141.5KACC
7$263,064$94,444.05$18,175$1,604.53+$244.9KACC
8$446,354$164,875.99$21,009$2,252.68+$425.3KACC
9$770,164$292,565.00$24,911$3,229.73+$745.3KACC
10$1,352,001$527,925.04$30,458$4,749.88+$1.32MACC

ACC vs JNJ: Complete Analysis 2026

ACCStock

American Campus Communities, Inc. is the largest owner, manager and developer of high-quality student housing communities in the United States. The company is a fully integrated, self-managed and self-administered equity real estate investment trust (REIT) with expertise in the design, finance, development, construction management and operational management of student housing properties. As of September 30, 2020, American Campus Communities owned 166 student housing properties containing approximately 111,900 beds. Including its owned and third-party managed properties, ACC's total managed portfolio consisted of 204 properties with approximately 139,900 beds.

Full ACC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ACC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACC vs SCHDACC vs JEPIACC vs OACC vs KOACC vs MAINACC vs ABBVACC vs MRKACC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.